IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-36316-3.html
   My bibliography  Save this article

Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches

Author

Listed:
  • Xiaolong Cheng

    (Children’s National Hospital
    George Washington University)

  • Zexu Li

    (Northeastern University)

  • Ruocheng Shan

    (Children’s National Hospital
    George Washington University)

  • Zihan Li

    (Northeastern University)

  • Shengnan Wang

    (Northeastern University)

  • Wenchang Zhao

    (Northeastern University)

  • Han Zhang

    (Northeastern University)

  • Lumen Chao

    (Children’s National Hospital
    George Washington University)

  • Jian Peng

    (University of Illinois at Urbana-Champaign)

  • Teng Fei

    (Northeastern University)

  • Wei Li

    (Children’s National Hospital
    George Washington University)

Abstract

A major challenge in the application of the CRISPR-Cas13d system is to accurately predict its guide-dependent on-target and off-target effect. Here, we perform CRISPR-Cas13d proliferation screens and design a deep learning model, named DeepCas13, to predict the on-target activity from guide sequences and secondary structures. DeepCas13 outperforms existing methods to predict the efficiency of guides targeting both protein-coding and non-coding RNAs. Guides targeting non-essential genes display off-target viability effects, which are closely related to their on-target efficiencies. Choosing proper negative control guides during normalization mitigates the associated false positives in proliferation screens. We apply DeepCas13 to the guides targeting lncRNAs, and identify lncRNAs that affect cell viability and proliferation in multiple cell lines. The higher prediction accuracy of DeepCas13 over existing methods is extensively confirmed via a secondary CRISPR-Cas13d screen and quantitative RT-PCR experiments. DeepCas13 is freely accessible via http://deepcas13.weililab.org .

Suggested Citation

  • Xiaolong Cheng & Zexu Li & Ruocheng Shan & Zihan Li & Shengnan Wang & Wenchang Zhao & Han Zhang & Lumen Chao & Jian Peng & Teng Fei & Wei Li, 2023. "Modeling CRISPR-Cas13d on-target and off-target effects using machine learning approaches," Nature Communications, Nature, vol. 14(1), pages 1-14, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36316-3
    DOI: 10.1038/s41467-023-36316-3
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-36316-3
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-36316-3?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Dirk Grimm & Konrad L. Streetz & Catherine L. Jopling & Theresa A. Storm & Kusum Pandey & Corrine R. Davis & Patricia Marion & Felix Salazar & Mark A. Kay, 2006. "Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways," Nature, Nature, vol. 441(7092), pages 537-541, May.
    2. Julia Joung & Jesse M. Engreitz & Silvana Konermann & Omar O. Abudayyeh & Vanessa K. Verdine & Francois Aguet & Jonathan S. Gootenberg & Neville E. Sanjana & Jason B. Wright & Charles P. Fulco & Yuen-, 2017. "Erratum: Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood," Nature, Nature, vol. 549(7672), pages 418-418, September.
    3. Omar O. Abudayyeh & Jonathan S. Gootenberg & Patrick Essletzbichler & Shuo Han & Julia Joung & Joseph J. Belanto & Vanessa Verdine & David B. T. Cox & Max J. Kellner & Aviv Regev & Eric S. Lander & Da, 2017. "RNA targeting with CRISPR–Cas13," Nature, Nature, vol. 550(7675), pages 280-284, October.
    4. Josh Tycko & Michael Wainberg & Georgi K. Marinov & Oana Ursu & Gaelen T. Hess & Braeden K. Ego & Aradhana & Amy Li & Alisa Truong & Alexandro E. Trevino & Kaitlyn Spees & David Yao & Irene M. Kaplow , 2019. "Mitigation of off-target toxicity in CRISPR-Cas9 screens for essential non-coding elements," Nature Communications, Nature, vol. 10(1), pages 1-14, December.
    5. Cheri M. Ackerman & Cameron Myhrvold & Sri Gowtham Thakku & Catherine A. Freije & Hayden C. Metsky & David K. Yang & Simon H. Ye & Chloe K. Boehm & Tinna-Sólveig F. Kosoko-Thoroddsen & Jared Kehe & Ti, 2020. "Massively multiplexed nucleic acid detection with Cas13," Nature, Nature, vol. 582(7811), pages 277-282, June.
    6. Kim F. Marquart & Ahmed Allam & Sharan Janjuha & Anna Sintsova & Lukas Villiger & Nina Frey & Michael Krauthammer & Gerald Schwank, 2021. "Predicting base editing outcomes with an attention-based deep learning algorithm trained on high-throughput target library screens," Nature Communications, Nature, vol. 12(1), pages 1-9, December.
    7. Julia Joung & Jesse M. Engreitz & Silvana Konermann & Omar O. Abudayyeh & Vanessa K. Verdine & Francois Aguet & Jonathan S. Gootenberg & Neville E. Sanjana & Jason B. Wright & Charles P. Fulco & Yuen-, 2017. "Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood," Nature, Nature, vol. 548(7667), pages 343-346, August.
    8. David W. Morgens & Michael Wainberg & Evan A. Boyle & Oana Ursu & Carlos L. Araya & C. Kimberly Tsui & Michael S. Haney & Gaelen T. Hess & Kyuho Han & Edwin E. Jeng & Amy Li & Michael P. Snyder & Will, 2017. "Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens," Nature Communications, Nature, vol. 8(1), pages 1-8, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Yocelyn Recinos & Dmytro Ustianenko & Yow-Tyng Yeh & Xiaojian Wang & Martin Jacko & Lekha V. Yesantharao & Qiyang Wu & Chaolin Zhang, 2024. "CRISPR-dCas13d-based deep screening of proximal and distal splicing-regulatory elements," Nature Communications, Nature, vol. 15(1), pages 1-15, December.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Teresa Maria Rosaria Noviello & Anna Maria Giacomo & Francesca Pia Caruso & Alessia Covre & Roberta Mortarini & Giovanni Scala & Maria Claudia Costa & Sandra Coral & Wolf H. Fridman & Catherine Sautès, 2023. "Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    2. Heike Chauvistré & Batool Shannan & Sheena M. Daignault-Mill & Robert J. Ju & Daniel Picard & Stefanie Egetemaier & Renáta Váraljai & Christine S. Gibhardt & Antonio Sechi & Farnusch Kaschani & Oliver, 2022. "Persister state-directed transitioning and vulnerability in melanoma," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    3. Adam E. Hall & Sebastian Öther-Gee Pohl & Patrizia Cammareri & Stuart Aitken & Nicholas T. Younger & Michela Raponi & Caroline V. Billard & Alfonso Bolado Carrancio & Aslihan Bastem & Paz Freile & Fio, 2022. "RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer," Nature Communications, Nature, vol. 13(1), pages 1-19, December.
    4. Anastasia Samarkina & Markus Kirolos Youssef & Paola Ostano & Soumitra Ghosh & Min Ma & Beatrice Tassone & Tatiana Proust & Giovanna Chiorino & Mitchell P. Levesque & Sandro Goruppi & Gian Paolo Dotto, 2023. "Androgen receptor is a determinant of melanoma targeted drug resistance," Nature Communications, Nature, vol. 14(1), pages 1-19, December.
    5. Alexendar R. Perez & Laura Sala & Richard K. Perez & Joana A. Vidigal, 2021. "CSC software corrects off-target mediated gRNA depletion in CRISPR-Cas9 essentiality screens," Nature Communications, Nature, vol. 12(1), pages 1-11, December.
    6. David N. Fiflis & Nicolas A. Rey & Harshitha Venugopal-Lavanya & Beatrice Sewell & Aaron Mitchell-Dick & Katie N. Clements & Sydney Milo & Abigail R. Benkert & Alan Rosales & Sophia Fergione & Aravind, 2024. "Repurposing CRISPR-Cas13 systems for robust mRNA trans-splicing," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    7. Zhifang Li & Ruochen Guo & Xiaozhi Sun & Guoling Li & Zhuang Shao & Xiaona Huo & Rongrong Yang & Xinyu Liu & Xi Cao & Hainan Zhang & Weihong Zhang & Xiaoyin Zhang & Shuangyu Ma & Meiling Zhang & Yuanh, 2024. "Engineering a transposon-associated TnpB-ωRNA system for efficient gene editing and phenotypic correction of a tyrosinaemia mouse model," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    8. Evan A. Schwartz & Jack P. K. Bravo & Mohd Ahsan & Luis A. Macias & Caitlyn L. McCafferty & Tyler L. Dangerfield & Jada N. Walker & Jennifer S. Brodbelt & Giulia Palermo & Peter C. Fineran & Robert D., 2024. "RNA targeting and cleavage by the type III-Dv CRISPR effector complex," Nature Communications, Nature, vol. 15(1), pages 1-14, December.
    9. Sri Gowtham Thakku & Jackson Lirette & Kanagavel Murugesan & Julie Chen & Grant Theron & Niaz Banaei & Paul C. Blainey & James Gomez & Sharon Y. Wong & Deborah T. Hung, 2023. "Genome-wide tiled detection of circulating Mycobacterium tuberculosis cell-free DNA using Cas13," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    10. Andrew Bo Liu & Daniel Lee & Amogh Prabhav Jalihal & William P. Hanage & Michael Springer, 2023. "Quantitatively assessing early detection strategies for mitigating COVID-19 and future pandemics," Nature Communications, Nature, vol. 14(1), pages 1-10, December.
    11. Yage Ding & Cristina Tous & Jaehoon Choi & Jingyao Chen & Wilson W. Wong, 2024. "Orthogonal inducible control of Cas13 circuits enables programmable RNA regulation in mammalian cells," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    12. Miguel M. Álvarez & Josep Biayna & Fran Supek, 2022. "TP53-dependent toxicity of CRISPR/Cas9 cuts is differential across genomic loci and can confound genetic screening," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    13. Zhichen Xu & Dongjuan Chen & Tao Li & Jiayu Yan & Jiang Zhu & Ting He & Rui Hu & Ying Li & Yunhuang Yang & Maili Liu, 2022. "Microfluidic space coding for multiplexed nucleic acid detection via CRISPR-Cas12a and recombinase polymerase amplification," Nature Communications, Nature, vol. 13(1), pages 1-14, December.
    14. Xiangyu Deng & Emmanuel Osikpa & Jie Yang & Seye J. Oladeji & Jamie Smith & Xue Gao & Yang Gao, 2023. "Structural basis for the activation of a compact CRISPR-Cas13 nuclease," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    15. Jianli Tao & Daniel E. Bauer & Roberto Chiarle, 2023. "Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing," Nature Communications, Nature, vol. 14(1), pages 1-16, December.
    16. Huang, Fengfeng & Guo, Pengfei & Wang, Yulan, 2022. "Optimal group testing strategy for the mass screening of SARS-CoV-2," Omega, Elsevier, vol. 112(C).
    17. Perla Pucci & Liam C. Lee & Miaojun Han & Jamie D. Matthews & Leila Jahangiri & Michaela Schlederer & Eleanor Manners & Annabel Sorby-Adams & Joshua Kaggie & Ricky M. Trigg & Christopher Steel & Lucy , 2024. "Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    18. Duško Lainšček & Vida Forstnerič & Veronika Mikolič & Špela Malenšek & Peter Pečan & Mojca Benčina & Matjaž Sever & Helena Podgornik & Roman Jerala, 2022. "Coiled-coil heterodimer-based recruitment of an exonuclease to CRISPR/Cas for enhanced gene editing," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    19. Annabel K. Sangree & Audrey L. Griffith & Zsofia M. Szegletes & Priyanka Roy & Peter C. DeWeirdt & Mudra Hegde & Abby V. McGee & Ruth E. Hanna & John G. Doench, 2022. "Benchmarking of SpCas9 variants enables deeper base editor screens of BRCA1 and BCL2," Nature Communications, Nature, vol. 13(1), pages 1-17, December.
    20. Breanna DiAndreth & Noreen Wauford & Eileen Hu & Sebastian Palacios & Ron Weiss, 2022. "PERSIST platform provides programmable RNA regulation using CRISPR endoRNases," Nature Communications, Nature, vol. 13(1), pages 1-11, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-36316-3. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.